跳至主要内容
临床试验/NCT05652582
NCT05652582已完成不适用

Seroprevalence of SARS-CoV 2 in the Staff of the University Hospitals of Strasbourg

University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 5,694 人开始时间: 2021年6月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
5,694
试验地点
1
主要终点
To determine the positive seroprevalence of SARS-CoV-2 among hospital staff screened from June 22, 2020 to November 1, 2020

研究概览

简要总结

The Grand Est region is one of the most affected regions in France during the first wave of the COVID-19 epidemic. A significant increase in the number of patients hospitalized for SARS-CoV 2 infection at the University Hospitals of Strasbourg (HUS) led to a sudden saturation of their capacities. Hospital workers appear to be a population at particular risk for this new infectious agent. The percentage of hospital workers who have been in contact with the virus or have contracted COVID-19 is unknown.

The objective of this work is to determine the prevalence of SARS-CoV-2 positive serologies among hospital staff screened from June 22, 2020 to November 1, 2020 following a screening campaign offering serological testing to all volunteer HUS professionals.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

To determine the positive seroprevalence of SARS-CoV-2 among hospital staff screened from June 22, 2020 to November 1, 2020

时间窗: Files analysed retrospectively from June 22, 2020 to November 1, 2020 will be examined

Seroprevalence will be estimated by calculating the rate of seropositive subjects with its 95% confidence interval

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验